Verel I - Search Results

1

High-quality 124I-labelled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy.

Verel I, Visser GW, Vosjan MJ, Finn R, Boellaard R, van Dongen GA. Verel I, et al. Eur J Nucl Med Mol Imaging. 2004 Dec;31(12):1645-52. doi: 10.1007/s00259-004-1632-8. Epub 2004 Jul 31. Eur J Nucl Med Mol Imaging. 2004. PMID: 15290121

2

89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.

Verel I, Visser GW, Boellaard R, Stigter-van Walsum M, Snow GB, van Dongen GA. Verel I, et al. J Nucl Med. 2003 Aug;44(8):1271-81. J Nucl Med. 2003. PMID: 12902418 Free article.

3

Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET.

Verel I, Visser GW, Boerman OC, van Eerd JE, Finn R, Boellaard R, Vosjan MJ, Stigter-van Walsum M, Snow GB, van Dongen GA. Verel I, et al. Cancer Biother Radiopharm. 2003 Aug;18(4):655-61. doi: 10.1089/108497803322287745. Cancer Biother Radiopharm. 2003. PMID: 14503961

4

Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.

Verel I, Visser GW, Boellaard R, Boerman OC, van Eerd J, Snow GB, Lammertsma AA, van Dongen GA. Verel I, et al. J Nucl Med. 2003 Oct;44(10):1663-70. J Nucl Med. 2003. PMID: 14530484 Free article.

5

The promise of immuno-PET in radioimmunotherapy.

Verel I, Visser GW, van Dongen GA. Verel I, et al. J Nucl Med. 2005 Jan;46 Suppl 1:164S-71S. J Nucl Med. 2005. PMID: 15653665 Free article. Review.

6

Radioimmunodiagnosis of lymph node metastases in head and neck cancer.

de Bree R, Roos JC, Verel I, van Dongen GA, Snow GB. de Bree R, et al. Among authors: verel i. Oral Dis. 2003 Sep;9(5):241-8. doi: 10.1034/j.1601-0825.2003.02864.x. Oral Dis. 2003. PMID: 14628891

7

Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44V6 in nude mice bearing head-and-neck cancer xenografts.

Verel I, Heider KH, Siegmund M, Ostermann E, Patzelt E, Sproll M, Snow GB, Adolf GR, van Dongen GA. Verel I, et al. Int J Cancer. 2002 May 20;99(3):396-402. doi: 10.1002/ijc.10369. Int J Cancer. 2002. PMID: 11992408

8

PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats.

Brouwers A, Verel I, Van Eerd J, Visser G, Steffens M, Oosterwijk E, Corstens F, Oyen W, Van Dongen G, Boerman O. Brouwers A, et al. Among authors: verel i. Cancer Biother Radiopharm. 2004 Apr;19(2):155-63. doi: 10.1089/108497804323071922. Cancer Biother Radiopharm. 2004. PMID: 15186595 Free article.

9

Noninvasive visualization of tumoral fibrin deposition using a peptidic fibrin-binding single photon emission computed tomography tracer.

Starmans LW, van Mourik T, Rossin R, Verel I, Nicolay K, Grüll H. Starmans LW, et al. Among authors: verel i. Mol Pharm. 2015 Jun 1;12(6):1921-8. doi: 10.1021/mp500673u. Epub 2015 May 14. Mol Pharm. 2015. PMID: 25922977

10

A key role for galectin-1 in sprouting angiogenesis revealed by novel rationally designed antibodies.

van Beijnum JR, Thijssen VL, Läppchen T, Wong TJ, Verel I, Engbersen M, Schulkens IA, Rossin R, Grüll H, Griffioen AW, Nowak-Sliwinska P. van Beijnum JR, et al. Among authors: verel i. Int J Cancer. 2016 Aug 15;139(4):824-35. doi: 10.1002/ijc.30131. Epub 2016 May 5. Int J Cancer. 2016. PMID: 27062254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters